News Archives - Page 551 of 690

WednesdayAug 07, 2019 11:23 am

First Bitcoin Capital Corp. (BITCF) Prepares to Leverage its Acquisition of First Bitcoin ATM Patent

First Bitcoin Capital is advancing its status as a blockchain tech developer by acquiring the nation’s first bitcoin ATM patent, which it believes controls all bitcoin ATMs and kiosks in the United States First Bitcoin is preparing to enforce its patent rights, which it predicts should be worth more than $50 million in profits during the coming five years More than 3,000 bitcoin ATMs are currently operating in the United States, and an average of 3.7 bitcoin ATMs are being added each day First Bitcoin is also launching an ATM check-cashing service for unbanked payday customers, and it expects to…

WednesdayAug 07, 2019 10:53 am

INmune Bio Inc. (NASDAQ: INMB) Planning Phase II Trial of INB03 as Part of Combination Immunotherapy for Cancer Patients

INmune Bio is currently attending the Cambridge Healthcare Institute’s 7th Annual Immuno-Oncology Summit in Boston Co-founder and CEO Dr. RJ Tesi is presenting positive preliminary data on INB03, which is being developed as part of a combination immunotherapy to potentially reverse resistance to treatment The annual immuno-oncology summit brings together leaders from across the immunotherapy industry and provides unique opportunities to connect scientists with the latest discoveries in the field An international mix of thought leaders and decision makers from the international immunotherapy and immuno-oncology community are gathering in Boston this week, with INmune Bio co-founder and CEO Dr. RJ…

TuesdayAug 06, 2019 11:56 am

Trxade Group Inc. (TRXD) Foresees Growth Opportunities in 2019, New Product Offerings on the Way

Financial results for the second quarter of 2019 have Trxade Group’s managerial team optimistic about the future of the brand and its digital platforms The company already has over 10,500 members for its pharmacy trading platform Independent pharmacies face many challenges when it comes to securing cost-efficient drugs, and Trxade Group has the technology to address these issues and continue building new industry-relevant products in the future Trxade Group Inc. (OTCQB: TRXD), an integrated pharmaceutical logistical service company, expects its new product lines to generate profitability in the coming months of 2019 and beyond, CEO and chairman Suren Ajjarapu said…

TuesdayAug 06, 2019 11:18 am

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Reviews Expansion of Client Base, Noting Unprecedented Number of License Agreements

Lexaria’s patented DehydraTECH technology improves taste, achieves higher absorption rates and promotes fast onset of bioactive compounds, including nicotine and cannabinoids Nine corporate licensees have signed a total of 11 definitive contracts to use DehydraTECH technology in innovative beverages, edibles and oral products Lexaria expects to experience unprecedented revenue growth as many of its clients plan aggressive rollouts and growth for their product lines Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) is expanding its family of existing licensees and partners with an impressive lineup of new corporate licensees for use of Lexaria’s patented DehydraTECH…

MondayAug 05, 2019 12:46 pm

Grapefruit Boulevard Investments Inc. (IGNG) Files Registration Statement, Anticipates Funding of Second Tranche

Grapefruit recently filed a registration statement with the SEC The company is one of the earliest registered cannabis distribution firms to attain an annually renewable license Following the registration statement, Grapefruit’s second funding tranche is expected to be released this week California-based Grapefruit Boulevard Investments Inc. (OTCQB: IGNG), a fully licensed premier cannabis manufacturer and distributor in the California legal cannabis marketplace, has filed a registration statement with the SEC on Form S-1 to register shares of the company’s common stock underlying the $600,000 convertible note recently issued to an institutional investor, as well as other securities to be issued…

MondayAug 05, 2019 12:02 pm

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Paves Way for New Cannabis Brand, B2B Sales through Partnership with Alcohol-Free Beverage Maker

Lexaria Bioscience’s revolutionary DehydraTECH technology enables cannabis consumers to experience rapid-on, rapid-off effects in non-smoked formulations A just-announced joint manufacturing partnership between Lexaria and alcohol-free beverage maker Hill Street Beverage Company is paving the way for wider distribution of Lexaria’s platform Hill Street is the only company to have gained licenses to use DehydraTECH on a global basis, taking advantage of Lexaria’s multiple international granted and pending patents By 2024, cannabis-infused beverage sales are expected to rise by nearly 15 times from last year’s revenues of $89 million The exploding interest in cannabis products and in new ways of enjoying…

MondayAug 05, 2019 11:17 am

Marijuana Company of America Inc. (MCOA) Expands hempSMART Product Line, Begins Signups for Disruptive Cannabis Delivery Service

Prelaunch of the company’s cannabis delivery service, Viva Buds Inc., was recently announced, with signups now being accepted as the official August launch date nears MCOA’s revolutionary, nourishing cosmetic topical CBD formula, hempSMART Body Cream, is designed to set a new industry standard by helping to improve overall skin health The company’s expansion of wholly owned subsidiary hempSMART Ltd. into Europe continued with its recent entry into the Netherlands Marijuana Company of America Inc. (OTCQB: MCOA), an innovative hemp and cannabis corporation, continues to expand its portfolio with new products and avenues of customer service. As pioneers in the cannabis…

MondayAug 05, 2019 10:50 am

Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Knows that the Toy Business is Not a Game

Blue Hat reported 52 percent revenue growth and 76 percent net income growth for the nine months ended September 30, 2018 The company maintains a vast portfolio of proprietary technologies, patents, artwork copyrights, trademarks and software copyrights Retail sales of toys and games in China surged from RMB111.8 billion in 2012 to RMB276.6 billion in 2017 Global trends and government policies favor further growth The toy industry is not a frivolous pastime. In fact, the toy business offers a wealth of opportunity. The United States is currently the largest segment of global toy sales. However, in terms of growth prospects,…

FridayAug 02, 2019 12:07 pm

BMW Group (BMWYY) Pioneering Natural Solutions, Such as Hemp Biocomposites, as Emphasis on Environmental Friendliness Increases

BMW is among the leaders in the automotive industry in its efforts to improve environmental sustainability through the use of natural, biodegradable products and electrical power systems that eliminate carbon emissions The company’s BMW i sub-brand utilizes natural hemp fibers in strong biocomposites for vehicle bodies that provide environmentally friendly appeal while maintaining physical integrity BMW’s i3 was the among the top-three best-selling all-electric vehicles for three years in a row, demonstrating the market demand for BMW’s vision of earth-friendly production Pioneers crossing the North American Great Plains during the 19th Century used hemp canvas to outfit their covered wagons…

FridayAug 02, 2019 11:02 am

INmune Bio Inc. (NASDAQ: INMB) Presents Cancer Treatment Immunotherapy at Congress of International Drug Discovery Science & Technology

INmune Bio attended the 17th Annual Congress of International Drug Discovery Science & Technology in Japan Co-founder and CEO R.J. Tesi and Director of Neuroscience C.J. Barnum both participated in talks about the role of immunotherapy in the treatment of specific medical conditions The congress was a paramount event in the field of immunotherapy, allowing researchers to network, exchange ideas and discuss recent developments INmune Bio Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness patients’ innate immune systems to fight disease, presented its innovative cancer immunotherapy, as well as its Alzheimer’s disease drug candidate, during a…

Site Search

Company Search

Category: News